EDRH
RPRX

Edmond de Rothschild Holding’s Repros Therapeutics Inc. RPRX Stock Holding History

Edmond de Rothschild Holding’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-185,500
Closed -$1.38M – 921
2015
Q3 		$1.38M Buy
185,500
+3,000
+2% +$22.9K 0.03% 247
2015
Q2 		$1.3M Buy
+182,500
New +$1.42M 0.03% 261

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Edmond de Rothschild Holding's RPRX Position: Q4 2015 in Review

Edmond de Rothschild Holding sold out of Repros Therapeutics Inc. (RPRX) in Q4 2015, closing a stake of 185,500 shares — an estimated $1.38M sold.

Edmond de Rothschild Holding first reported a position in RPRX in Q2 2015 and held it in 2 quarters. The position peaked at $1.38M in Q3 2015. 56 funds tracked by Wall St. Rank hold RPRX as of Q4 2015.

  • Edmond de Rothschild Holding reported no remaining Repros Therapeutics Inc. position as of Q4 2015 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 185,500 Repros Therapeutics Inc. shares in Q4 2015, an estimated $1.38M.
  • Edmond de Rothschild Holding first reported a position in Repros Therapeutics Inc. in Q2 2015 and held it in 2 quarters.
  • Edmond de Rothschild Holding's Repros Therapeutics Inc. position peaked at $1.38M in Q3 2015.
  • 56 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2015.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2015, filed 16 Feb 2016.